Tue, Jul 07, 2026 - Page 5
946 indexed SquawkNews stories from this UTC day. Showing 481-600.
L
US Trade Balance Actual -77.6B (Forecast -78.4B, Previous -55.9B)
US Trade Balance Actual -77.6B (Forecast -78.4B, Previous -55.9B)
MACRO | Jul 07, 2026, 12:30 PM UTC
L
Canadian Trade Balance
Canadian Trade Balance
MACRO | Jul 07, 2026, 12:30 PM UTC
L
US Trade Balance
US Trade Balance
MACRO | Jul 07, 2026, 12:30 PM UTC
H
Mohamed El-Erian Warns Kevin Warsh's Fed Shake-Up Signals a 'Similar Re-Evaluation' of 'Excessive Data Dependency' Ahead
Driven by the reform-oriented approach of new Federal Reserve Chair Kevin Warsh, central banks are considering abandoning their historical reliance on “traditional” forward guidance, prompting top economist Mohamed El-Er
CENTRAL_BANK | Jul 07, 2026, 12:27 PM UTC
H
Moody's, S&P Global to Perform Better Than Expected, Morgan Stanley Says
() -- Moody's (MCO) and S&P Global (SPGI) are retaining restraining outlooks despite "strong tailwinds" and an increase in bond issuances that should bolster the ratings agencies' prospects, Morgan Stanley (MS) said in a
RATES | Jul 07, 2026, 12:26 PM UTC
L
Lawyers For Le Pen: She Will Reflect Following Court's Decision
Le Pen Left Court Without Speaking To Reporters
EQUITY | Jul 07, 2026, 12:26 PM UTC
L
Toyota Is Moving From Mexico To The United States (Texas!). A Really Big Deal. Tariffs At Work! @realDonaldTrump On Truth
Toyota Is Moving From Mexico To The United States (Texas!). A Really Big Deal. Tariffs At Work! @realDonaldTrump On Truth
EQUITY | Jul 07, 2026, 12:22 PM UTC
L
Trump on Truth Social: Toyota is moving from Mexico to the United States. Tariffs at work!
Trump on Truth Social: Toyota is moving from Mexico to the United States. Tariffs at work!
GEOPOLITICS | Jul 07, 2026, 12:22 PM UTC
L
Shell issues update on Q2 outlook
Shell issued an update to the second quarter 2026 outlook and gave an overview of its current expectations for the second quarter across its Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Ene
ENERGY | Jul 07, 2026, 12:20 PM UTC
L
IMF World Eco Outlook Update
IMF World Eco Outlook Update
EQUITY | Jul 07, 2026, 12:17 PM UTC
L
Trump meets Turkey's Erdogan - Watch Live
Trump meets Turkey's Erdogan - Watch Live
GEOPOLITICS | Jul 07, 2026, 12:17 PM UTC
H
USD/INR Falls as NDF Dollar Sales Lift Rupee 0.4%
() -- The Indian rupee rose to a one-week high of 94.95 against the US dollar on Tuesday, after offshore NDF dollar sales forced short-covering and wider Asian currency gains supported sentiment into the close. For the s
MACRO | Jul 07, 2026, 12:16 PM UTC
L
US ADP Weekly Employment Change Jun 20: 21.0K (prev 30.75K)
US ADP Weekly Employment Change Jun 20: 21.0K (prev 30.75K)
EQUITY | Jul 07, 2026, 12:15 PM UTC
L
US ADP Wkly Employment Change Actual 21k (Forecast -, Previous 30.75k)
US ADP Wkly Employment Change Actual 21k (Forecast -, Previous 30.75k)
EQUITY | Jul 07, 2026, 12:15 PM UTC
L
US ADP Wkly Employment Change
US ADP Wkly Employment Change
EQUITY | Jul 07, 2026, 12:15 PM UTC
H
United States Antimony announces wet commissioning of flotation mill
United States Antimony announced the wet commissioning of its critical mineral flotation mill located in Radersburg, Montana. The Company will celebrate this significant milestone with a Rock Breaking and Ribbon Cutting
EQUITY | Jul 07, 2026, 12:14 PM UTC
L
Global-e Online Insider Sold Shares Worth $920,321, According to a Recent SEC Filing
() -- Shahar Tamari, Director and Chief Operating Officer, on July 06, 2026, sold 24,999 shares in Global-e Online (GLBE) for $920,321. Following the Form 4 filing with the SEC, Tamari has control over a total of 3,931,6
REGULATION | Jul 07, 2026, 12:12 PM UTC
L
Wells Fargo Raises Discretionary, Staples To Equalweight
Wells Fargo Raises Discretionary, Staples To Equalweight
EQUITY | Jul 07, 2026, 12:12 PM UTC
H
Wall Street's Most Accurate Analysts Give Their Take On 3 Utilities Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. re
RATES | Jul 07, 2026, 12:12 PM UTC
L
Wells Fargo Cuts Energy, Materials To Underweight Vs Overweight
Industrials Raised To Overweight Vs Equalweight
EQUITY | Jul 07, 2026, 12:11 PM UTC
H
Lakewood-Amedex supports reintroduction of PASTEUR act
Lakewood-Amedex Biotherapeutics announced its support for the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance, PASTEUR, Act, legislation designed to "encourage" the dev
EQUITY | Jul 07, 2026, 12:10 PM UTC
L
Democratic Lawmakers Probe Lutnick’s Possible Ties to Cantor Fitzgerald Deal – WSJ
READ HERE
EQUITY | Jul 07, 2026, 12:05 PM UTC
H
Altria Group price target raised to $79 from $76 at UBS
UBS analyst Faham Baig raised the firm's price target on Altria Group to $79 from $76 and keeps a Buy rating on the shares. The firm updated its model ahead of the Q2 earnings report.
EQUITY | Jul 07, 2026, 12:05 PM UTC
L
Amazon seeks to raise at least $25b in US dollar bond sale.
Amazon seeks to raise at least $25b in US dollar bond sale.
RATES | Jul 07, 2026, 12:03 PM UTC
H
Samsung Q2 2026 Earnings
Samsung Q2 2026 Earnings
EARNINGS | Jul 07, 2026, 12:02 PM UTC
H
Investors Want Quarterly Earnings to Stay as SEC Weighs Reporting Shake-Up: Report
Investor groups have reportedly expressed their support for the continuation of quarterly reporting by publicly traded companies in response to a proposal advocating for semiannual reporting. The investment industry is p
EARNINGS | Jul 07, 2026, 12:02 PM UTC
H
Stocks fell as volatility returned to chipmakers after strong earnings from Samsung Electronics left investors expecting even more, while bo
Stocks fell as volatility returned to chipmakers after strong earnings from Samsung Electronics left investors expecting even more, while bonds slipped as Brent crude headed for its biggest gain in over a week.
RATES | Jul 07, 2026, 12:01 PM UTC
L
Morning Juice - US Session Prep (7th July)
Morning Juice - US Session Prep (7th July)
EQUITY | Jul 07, 2026, 12:00 PM UTC
L
Samsung sales 171.00T Won, est. 169.23T Won
Samsung sales 171.00T Won, est. 169.23T Won
EQUITY | Jul 07, 2026, 12:00 PM UTC
L
Secured Overnight Financing Rate 3.63% July 6 vs 3.64% July 2.
Secured Overnight Financing Rate 3.63% July 6 vs 3.64% July 2.
EQUITY | Jul 07, 2026, 11:59 AM UTC
L
Samsung Q2 Oper Profit 89.40T Won, est. 84.2T Won
Samsung Q2 Oper Profit 89.40T Won, est. 84.2T Won
EARNINGS | Jul 07, 2026, 11:59 AM UTC
H
US Dollar Rises Early Tuesday Ahead of Trade, Redbook, Consumer Sentiment
() -- The US dollar rose against its major trading partners early Tuesday, except for a decline versus the yen, ahead of the release of international trade data for May at 8:30 am ET and weekly Redbook same-store sales a
CENTRAL_BANK | Jul 07, 2026, 11:57 AM UTC
H
Wintrust Financial assumed with a Neutral at UBS
UBS assumed coverage of Wintrust Financial with a Neutral rating with a price target of $170, down from $176. Wintrust Financial is a high-quality compounder, and the debate is whether the premium multiple already captur
EARNINGS | Jul 07, 2026, 11:57 AM UTC
L
Trump Attends NATO Dinner
Trump Attends NATO Dinner
GEOPOLITICS | Jul 07, 2026, 11:56 AM UTC
L
Trump Meets With Turkey's pres
Trump Meets With Turkey's pres
GEOPOLITICS | Jul 07, 2026, 11:56 AM UTC
H
Tech Stock Decline, Oil Price Increase Dampen US Equity Futures Pre-Bell
() -- US equity futures were mostly lower pre-bell Tuesday as technology-related stocks dropped and oil prices rose after a couple of vessels were damaged in the Strait of Hormuz, potentially complicating peace talks to
RATES | Jul 07, 2026, 11:55 AM UTC
L
French Appeals Court Judges Sentence Le Pen To 100,000 Euro Fine, Three Years In Prison With Two Suspended And One Wearing Electronic Tag
French Appeals Court Judges Sentence Le Pen To 100,000 Euro Fine, Three Years In Prison With Two Suspended And One Wearing Electronic Tag
FX | Jul 07, 2026, 11:54 AM UTC
L
France's Le Pen cleared to run in 2027 French presidential race
France's Le Pen cleared to run in 2027 French presidential race
EQUITY | Jul 07, 2026, 11:54 AM UTC
L
Marine Le Pen Cleared To Run In Next Presidential Election
Marine Le Pen Cleared To Run In Next Presidential Election
EQUITY | Jul 07, 2026, 11:53 AM UTC
L
French Appeals Court Rules Le Pen Ineligible To Hold Public Office For 45 Months, 30 Suspended
To Pay 100K Euros Fines
EQUITY | Jul 07, 2026, 11:53 AM UTC
H
UAE Stocks in Green as Oil Gains Amid Fresh US-Iran Threats
() -- Shares in the United Arab Emirates remained in the green as the FTSE ADX General Index added 0.189% and the DFM General Index gained 0.055% at the close of Tuesday trading. Iranian Foreign Minister Seyed Abbas Arag
ENERGY | Jul 07, 2026, 11:51 AM UTC
H
Adnoc Distribution to Acquire Shell Downstream South Africa in $1 Billion Enterprise Value Deal
() -- Adnoc Distribution, a UAE-based fuel and convenience retailer and subsidiary of energy major Adnoc, Tuesday said it has agreed to acquire the 100% share capital of Shell Downstream South Africa from Shell South Afr
EARNINGS | Jul 07, 2026, 11:51 AM UTC
L
Le Pen Found Guilty Of Embezzlement; Decision On Ban To Follow
Le Pen Found Guilty Of Embezzlement; Decision On Ban To Follow
EQUITY | Jul 07, 2026, 11:50 AM UTC
L
Sweden's Kristersson: NATO Committed To Orderly Burden-Shifting
Sweden's Kristersson: NATO Committed To Orderly Burden-Shifting
GEOPOLITICS | Jul 07, 2026, 11:50 AM UTC
H
Earnings Flash (ARIS) Aris Mining Reports Q2 Gold Revenue $320M
() -- Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduction is strictly prohibited.
EARNINGS | Jul 07, 2026, 11:48 AM UTC
L
New Deal: Amazon.Com Inc $Benchmark 8-Tranche Bond Sale
New Deal: Amazon.Com Inc $Benchmark 8-Tranche Bond Sale
RATES | Jul 07, 2026, 11:46 AM UTC
H
Corning price target raised to $230 from $210 at Oppenheimer
Oppenheimer analyst Martin Yang raised the firm's price target on Corning to $230 from $210 and keeps an Outperform rating on the shares following bullish takeaways from BOE's IR day last week. At that event, BOE Technol
CENTRAL_BANK | Jul 07, 2026, 11:46 AM UTC
L
Alterity Therapeutics Says FDA Backs Phase 3 Design for Multiple System Atrophy Therapy
() -- Alterity Therapeutics (ATHE) said Tuesday the US Food and Drug Administration's end-of-phase 2 meeting minutes confirmed agreement on the key elements of the registrational phase 3 trial for ATH434 in multiple syst
REGULATION | Jul 07, 2026, 11:45 AM UTC
L
BofA Liquid Insight: Yen intervention FAQ
Key takeaways JPY at multi-decade lows; intervention checklist nearly complete, but effectiveness hinges on the broader USD cycle. MoF may embrace "constructive ambiguity"; Korea coordination talk, US participation unlik
FX | Jul 07, 2026, 11:45 AM UTC
L
Attacked Qatari LNG Tanker Al Rekayyat Is At Risk Of Exploding Due To A Fire In Its Engine Room — Source Briefed On The Incident To Reuters
Attacked Qatari LNG Tanker Al Rekayyat Is At Risk Of Exploding Due To A Fire In Its Engine Room — Source Briefed On The Incident To Reuters
ENERGY | Jul 07, 2026, 11:44 AM UTC
L
Attacked Qatari LNG tanker Al Reykat is at risk of exploding due to a fire in its engine room — Source briefed on the incident
Attacked Qatari LNG tanker Al Reykat is at risk of exploding due to a fire in its engine room — Source briefed on the incident
ENERGY | Jul 07, 2026, 11:44 AM UTC
L
French Appeals Court Presiding Judge: Immediate Application Of Ban On Public Office Is Not Automatic, For Court To Decide
French Appeals Court Presiding Judge: Immediate Application Of Ban On Public Office Is Not Automatic, For Court To Decide
EQUITY | Jul 07, 2026, 11:44 AM UTC
L
French Budget Minister Amiel: Plan €3B more cuts in 2026
French Budget Minister Amiel: Plan €3B more cuts in 2026
GEOPOLITICS | Jul 07, 2026, 11:43 AM UTC
L
French Appeals Court Presiding Judge: The Facts In Marine Le Pen, RN Case Are Serious, Involve More Than 2M Euros
French Appeals Court Presiding Judge: The Facts In Marine Le Pen, RN Case Are Serious, Involve More Than 2M Euros
EQUITY | Jul 07, 2026, 11:42 AM UTC
H
Semiconductor Sentiments Soften European Bourses Midday
() -- European bourses tracked moderately lower midday Tuesday, as the international downdraft on tech stocks blew across Europe. Food and property stocks led gains on continental trading floors, while oil shares also la
MACRO | Jul 07, 2026, 11:41 AM UTC
H
US Briefing 07/07/2026: NATO Touts Defense Deals To Show Trump It Is Stepping Up; Samsung Shares Tumble 10% Despite Record Q2 Profit
Qatar LNG Ship Struck In Hormuz; Testing US-Iran Deal NATO Touts Defense Deals To Show Trump It Is Stepping Up Trump Considered 1/3 Troop Cuts To Send Europe A Message ECB Panetta: Sees Fragile Outlook With Risks To Infl
CENTRAL_BANK | Jul 07, 2026, 11:40 AM UTC
L
France Fin. Min. Lescure: It's difficult to achieve 5% deficit target for this year
France Fin. Min. Lescure: It's difficult to achieve 5% deficit target for this year
EQUITY | Jul 07, 2026, 11:39 AM UTC
H
Orvana Minerals Expects Mid-July Start-Up of Don Mario Oxide Stockpile Project
() -- Orvana Minerals (ORV.TO) subsidiary Empresa Minera Paititi (EMIPA) expects start-up activities at the Don Mario Oxide Stockpile Project in Bolivia to begin in mid-July following a delay caused by logistics disrupti
EARNINGS | Jul 07, 2026, 11:38 AM UTC
H
Ukraine Pres Zelenskiy: Plans To Discuss Air Defences With Trump On Wednesday
Ukraine Pres Zelenskiy: Plans To Discuss Air Defences With Trump On Wednesday
GEOPOLITICS | Jul 07, 2026, 11:36 AM UTC
H
Aris Mining reports Q2 consolidated gold production of 73.7 koz
Aris Mining reports gold production of 148.0 thousand ounces for the six months ended June 30, a 31% increase over H1 2025. Gold sales of 147.0 koz in H1 2026 generated revenue of over $680M. The Company remains on track
COMMODITIES | Jul 07, 2026, 11:35 AM UTC
L
Agios Says US FDA Grants Priority Review for Mitapivat to Treat Sickle Cell Disease
() -- Agios Pharmaceuticals (AGIO) said Tuesday that the US Food and Drug Administration granted Priority Review to its supplemental new drug application for mitapivat, an oral pyruvate kinase activator, for the treatmen
REGULATION | Jul 07, 2026, 11:33 AM UTC
H
Rhythm Pharmaceuticals price target raised to $141 from $137 at RBC Capital
RBC Capital raised the firm's price target on Rhythm Pharmaceuticals to $141 from $137 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector
EQUITY | Jul 07, 2026, 11:32 AM UTC
L
Alterity Therapeutics receives FDA meeting minutes on pathway for ATH434
Alterity Therapeutics announced that it has received the official meeting minutes from its End-of Phase-2 meeting for ATH434 in Multiple System Atrophy from the FDA. The minutes confirm the elements of the registrational
REGULATION | Jul 07, 2026, 11:32 AM UTC
H
Verastem price target lowered to $14 from $15 at RBC Capital
RBC Capital lowered the firm's price target on Verastem to $14 from $15 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up
EQUITY | Jul 07, 2026, 11:32 AM UTC
H
Mirum Pharmaceuticals price target raised to $148 from $142 at RBC Capital
RBC Capital analyst Lisa Walter raised the firm's price target on Mirum Pharmaceuticals to $148 from $142 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech.
EQUITY | Jul 07, 2026, 11:32 AM UTC
H
Berenberg Lifts Keller Group Price Target, Estimates After FY26 Outlook Upgrade
() -- Berenberg raised its price target and earnings projections for Keller Group (KLR.L) after the company's surprise first-half trading update included an upgraded full-year guidance. "Both revenue and underlying EBIT
EARNINGS | Jul 07, 2026, 11:32 AM UTC
H
Legend Biotech price target lowered to $63 from $64 at RBC Capital
RBC Capital analyst Leonid Timashev lowered the firm's price target on Legend Biotech to $63 from $64 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The
EQUITY | Jul 07, 2026, 11:31 AM UTC
H
Ideaya Biosciences price target lowered to $48 from $53 at RBC Capital
RBC Capital lowered the firm's price target on Ideaya Biosciences to $48 from $53 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has
EQUITY | Jul 07, 2026, 11:31 AM UTC
H
Nuvation Bio price target lowered to $19 from $20 at RBC Capital
RBC Capital lowered the firm's price target on Nuvation Bio to $19 from $20 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked
RATES | Jul 07, 2026, 11:31 AM UTC
H
Exelixis price target raised to $46 from $43 at RBC Capital
RBC Capital raised the firm's price target on Exelixis to $46 from $43 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked u
EQUITY | Jul 07, 2026, 11:30 AM UTC
H
Cytokinetics price target lowered to $117 from $119 at RBC Capital
RBC Capital analyst Leonid Timashev lowered the firm's price target on Cytokinetics to $117 from $119 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The
EQUITY | Jul 07, 2026, 11:30 AM UTC
H
BeOne Medicines price target raised to $451 from $436 at RBC Capital
RBC Capital raised the firm's price target on BeOne Medicines to $451 from $436 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has pi
RATES | Jul 07, 2026, 11:30 AM UTC
H
Axsome Therapeutics price target raised to $304 from $302 at RBC Capital
RBC Capital analyst Leonid Timashev raised the firm's price target on Axsome Therapeutics to $304 from $302 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotec
EQUITY | Jul 07, 2026, 11:30 AM UTC
H
CorMedix price target lowered to $13 from $14 at RBC Capital
RBC Capital lowered the firm's price target on CorMedix to $13 from $14 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up
EQUITY | Jul 07, 2026, 11:30 AM UTC
L
French Appeals Court In Session To Deliver Verdict In Marine Le Pen, National Rally Case
French Appeals Court In Session To Deliver Verdict In Marine Le Pen, National Rally Case
EQUITY | Jul 07, 2026, 11:29 AM UTC
H
Ultragenyx price target raised to $40 from $35 at RBC Capital
RBC Capital raised the firm's price target on Ultragenyx to $40 from $35 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up
EQUITY | Jul 07, 2026, 11:28 AM UTC
H
Moderna price target raised to $45 from $38 at RBC Capital
RBC Capital raised the firm's price target on Moderna to $45 from $38 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up
EQUITY | Jul 07, 2026, 11:28 AM UTC
H
BioMarin price target lowered to $62 from $66 at RBC Capital
RBC Capital analyst Luca Issi lowered the firm's price target on BioMarin to $62 from $66 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech
RATES | Jul 07, 2026, 11:28 AM UTC
H
Argenx price target raised to $945 from $890 at RBC Capital
RBC Capital raised the firm's price target on Argenx to $945 from $890 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up c
EQUITY | Jul 07, 2026, 11:28 AM UTC
H
Ascendis Pharma price target raised to $280 from $275 at RBC Capital
RBC Capital raised the firm's price target on Ascendis Pharma to $280 from $275 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has pi
RATES | Jul 07, 2026, 11:28 AM UTC
H
Honeywell price target lowered to $250 from $260 at JPMorgan
JPMorgan analyst Chigusa Katoku lowered the firm's price target on Honeywell (HON) to $250 from $260 and keeps an Overweight rating on the shares after updating the firm's model to reflect the Honeywell Aerospace (HONA)
EARNINGS | Jul 07, 2026, 11:28 AM UTC
H
Agios Pharmaceuticals price target raised to $32 from $28 at RBC Capital
RBC Capital raised the firm's price target on Agios Pharmaceuticals to $32 from $28 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector
EQUITY | Jul 07, 2026, 11:27 AM UTC
H
Regeneron price target lowered to $696 from $707 at RBC Capital
RBC Capital lowered the firm's price target on Regeneron to $696 from $707 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has pick
RATES | Jul 07, 2026, 11:27 AM UTC
H
Vertex Pharmaceuticals price target raised to $570 from $543 at RBC Capital
RBC Capital raised the firm's price target on Vertex Pharmaceuticals to $570 from $543 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector
RATES | Jul 07, 2026, 11:27 AM UTC
H
Stocks declined as volatility returned to semiconductor shares after Samsung' earnings failed to meet elevated investor expectations despite
Stocks declined as volatility returned to semiconductor shares after Samsung' earnings failed to meet elevated investor expectations despite a 19-fold surge in quarterly profit.
EARNINGS | Jul 07, 2026, 11:25 AM UTC
L
Canadian Foreign Minister Anand: Canada is on track for NATO's 5% defence spending target by 2035, having already reached 2%
Canadian Foreign Minister Anand: Canada is on track for NATO's 5% defence spending target by 2035, having already reached 2%
GEOPOLITICS | Jul 07, 2026, 11:25 AM UTC
H
United Securities Kicks Off Adnoc Gas Coverage at Buy on Growth Potential
() -- United Securities LLC on Monday began its coverage of Adnoc Gas (ADX:ADNOCGAS) with a buy rating and a price target of 3.95 Emirati dirhams. The research view is backed by the Emirati natural gas distributor's lead
RATES | Jul 07, 2026, 11:22 AM UTC
H
PTC Therapeutics price target raised to $85 from $82 at RBC Capital
RBC Capital raised the firm's price target on PTC Therapeutics to $85 from $82 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has
RATES | Jul 07, 2026, 11:22 AM UTC
H
Gilead price target lowered to $120 from $122 at RBC Capital
RBC Capital analyst Brian Abrahams lowered the firm's price target on Gilead to $120 from $122 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The bio
RATES | Jul 07, 2026, 11:21 AM UTC
H
Incyte price target raised to $99 from $95 at RBC Capital
RBC Capital raised the firm's price target on Incyte to $99 from $95 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up
EQUITY | Jul 07, 2026, 11:21 AM UTC
H
Neurocrine price target raised to $195 from $183 at RBC Capital
RBC Capital analyst Brian Abrahams raised the firm's price target on Neurocrine to $195 from $183 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The bio
EQUITY | Jul 07, 2026, 11:21 AM UTC
H
How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q2 Earnings
The Goldman Sachs Group, Inc. (NYSE: GS ) will release its second-quarter earnings report before the opening bell on Tuesday, July 14. Some of the bank’s investors may be eyeing potential dividend gains. Currently, the a
RATES | Jul 07, 2026, 11:21 AM UTC
H
Biogen price target raised to $242 from $227 at RBC Capital
RBC Capital raised the firm's price target on Biogen to $242 from $227 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up c
EQUITY | Jul 07, 2026, 11:21 AM UTC
L
Watch Live | NATO Industry Forum In Ankara, Turkey
WATCH HERE
GEOPOLITICS | Jul 07, 2026, 11:19 AM UTC
H
Annovis Bio Announces Full Enrollment Of Its Phase 3 Trial Of Buntanetap In Patients With Early Alzheimer’s Disease; The Trial Enrolled 850
Annovis Bio, Inc. (NYSE: ANVS ) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s dis
EARNINGS | Jul 07, 2026, 11:19 AM UTC
H
Canada Dollar Sees Near-Term Constraint but 2027 May Bring Support, National Bank Says
() -- The Canadian dollar is caught between improving domestic data and limited external support, but conditions might be in place late this year to provide support to the loonie in 2027, National Bank of Canada said in
MACRO | Jul 07, 2026, 11:18 AM UTC
H
Gilat Satellite announces $11M in DoW orders
Gilat Satellite announced that Gilat DataPath has received orders totaling $11M to supply field services and custom SATCOM terminals to the U.S. Department of War. Deliveries are expected over the next 12 months. The ord
GEOPOLITICS | Jul 07, 2026, 11:18 AM UTC
H
BioCryst price target raised to $14 from $13 at RBC Capital
RBC Capital raised the firm's price target on BioCryst to $14 from $13 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The biotech sector has picked up c
EQUITY | Jul 07, 2026, 11:18 AM UTC
L
Turkish Pres Erdogan Greets Trump At Ankara Airport
Turkish Pres Erdogan Greets Trump At Ankara Airport
GEOPOLITICS | Jul 07, 2026, 11:17 AM UTC
H
Eli Lilly price target raised to $1,400 from $1,300 at JPMorgan
JPMorgan raised the firm's price target on Eli Lilly to $1,400 from $1,300 and keeps an Overweight rating on the shares. The firm sees potential upside for Mounjaro from growth in the U.S. obesity market and internationa
EQUITY | Jul 07, 2026, 11:17 AM UTC
H
Acadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital
RBC Capital analyst Brian Abrahams raised the firm's price target on Acadia Pharmaceuticals to $36 from $29 and keeps an Outperform rating on the shares as part of a broader research note previewing Q2 earnings in Biotec
RATES | Jul 07, 2026, 11:16 AM UTC
H
Taiwan Inflation Hotter than Expected in June as Energy Prices Jump
() -- Taiwan's annual inflation print came in higher than expected and reached a 17-month high in June amid a surge in fuel prices during the period, the official data showed Tuesday. "The CPI in June 2026, compared with
MACRO | Jul 07, 2026, 11:15 AM UTC
M
US Stocks Drop as Samsung Attacks International Chipmakers – Europe Market Wrap
US Stocks Drop as Samsung Attacks International Chipmakers – Europe Market Wrap
EQUITY | Jul 07, 2026, 11:14 AM UTC
L
Canadian Foreign Minister Anand Tells Reuters We Want More Countries To Come On Board Defence, Security And Resilience Bank (DSRB) Before We
Canada Is Still In Discussions With Many Countries On Defence Bank. We Have A Critical Mass Of Countries Now
GEOPOLITICS | Jul 07, 2026, 11:13 AM UTC
H
LiveOne price target lowered to $11 from $14 at Alliance Global
Alliance Global analyst Brian Kinstlinger lowered the firm's price target on LiveOne to $11 from $14 and keeps a Buy rating on the shares following the Q4 earnings report. Growing its paid subscriber base is critical to
EARNINGS | Jul 07, 2026, 11:13 AM UTC
L
Agios Pharmaceuticals granted priority review for mitapivat sNDA
Agios Pharmaceuticals announced that the FDA has accepted its supplemental new drug application for mitapivat, an oral pyruvate kinase activator, in sickle cell disease with a priority review. The Prescription Drug User
EQUITY | Jul 07, 2026, 11:11 AM UTC
H
Humana price target raised to $300 from $264 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Humana to $300 from $264 and keeps a Neutral rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by manag
EQUITY | Jul 07, 2026, 11:10 AM UTC
H
HCA Healthcare price target lowered to $525 from $588 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm's price target on HCA Healthcare to $525 from $588 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management d
EQUITY | Jul 07, 2026, 11:09 AM UTC
H
Elevance Health price target raised to $450 from $400 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Elevance Health to $450 from $400 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, suppo
EQUITY | Jul 07, 2026, 11:09 AM UTC
H
CVS Health price target raised to $110 from $100 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm's price target on CVS Health to $110 from $100 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discus
EARNINGS | Jul 07, 2026, 11:09 AM UTC
H
RBC Tweaks Estimates for Elis Ahead of H1 Results; Sector Perform Rating Kept
() -- RBC Capital Markets adjusted its model for Elis (ELIS.PA), making minimal revisions to its earnings forecasts ahead of the French circular services company's first-half results presentation due July 29. "Our EPS es
EARNINGS | Jul 07, 2026, 11:08 AM UTC
H
Skyward Specialty Insurance price target raised to $68 from $55 at Piper Sandler
Piper Sandler raised the firm's price target on Skyward Specialty Insurance to $68 from $55 and keeps an Overweight rating on the shares. The firm is adjusting its model to change the definition of expense ratio to what
EQUITY | Jul 07, 2026, 11:08 AM UTC
H
Centene price target raised to $75 from $60 at Cantor Fitzgerald
Cantor Fitzgerald analyst Sarah James raised the firm's price target on Centene to $75 from $60 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by ma
EQUITY | Jul 07, 2026, 11:08 AM UTC
L
Leader Of Reform UK Nigel Farage: To Make A Statement On His Future In Public Life At 1400 BST
Leader Of Reform UK Nigel Farage: To Make A Statement On His Future In Public Life At 1400 BST
EQUITY | Jul 07, 2026, 11:08 AM UTC
H
Nano-X Imaging downgraded to Neutral from Buy at Alliance Global
Alliance Global downgraded Nano-X Imaging to Neutral from Buy with a price target of $3, down from $5, to reflect lower visibility into the revenue outlook after the company reported Q1 earnings and management removed 20
EARNINGS | Jul 07, 2026, 11:07 AM UTC
H
AerCap price target raised to $176 from $170 at Susquehanna
Susquehanna raised the firm's price target on AerCap to $176 from $170 and keeps a Positive rating on the shares. The firm said they see a constructive setup for the global lessor into 2Q earnings season as demand for ai
EQUITY | Jul 07, 2026, 11:07 AM UTC
H
Frontier Group price target raised to $7 from $4.50 at Susquehanna
Susquehanna analyst Christopher Stathoulopoulos raised the firm's price target on Frontier Group to $7 from $4.50 and keeps a Neutral rating on the shares. The firm said they see a constructive setup for the airlines int
EARNINGS | Jul 07, 2026, 11:06 AM UTC
H
United Airlines price target raised to $172 from $135 at Susquehanna
Susquehanna raised the firm's price target on United Airlines to $172 from $135 and keeps a Positive rating on the shares. The firm said they see a constructive setup for the airlines into 2Q earnings season as demand fo
EQUITY | Jul 07, 2026, 11:06 AM UTC
H
Southwest price target raised to $55 from $44 at Susquehanna
Susquehanna analyst Christopher Stathoulopoulos raised the firm's price target on Southwest to $55 from $44 and keeps a Neutral rating on the shares. The firm said they see a constructive setup for the airlines into 2Q e
EQUITY | Jul 07, 2026, 11:05 AM UTC
H
Delta Air Lines price target raised to $108 from $78 at Susquehanna
Susquehanna raised the firm's price target on Delta Air Lines to $108 from $78 and keeps a Positive rating on the shares. The firm said they see a constructive setup for the airlines into 2Q earnings season as demand for
EARNINGS | Jul 07, 2026, 11:05 AM UTC